The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $50.90

Today's change+0.65 +1.29%
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

Cambrex Corp

NYSE: CBM
Last

(U.S.) $50.90

Today's change+0.65 +1.29%
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.

Cambrex Corp crosses above 125-day moving average

Cambrex Corp closed up Wednesday by (U.S.)$0.65 or 1.29% to (U.S.)$50.90 and crossing above its 125-day moving average. Over the last five days, shares have gained 0.30%, but are down 5.65% for the last year to date. Shares have outperformed the S&P 500 by 6.79% during the last year.

Key company metrics

  • Open(U.S.) $50.30
  • Previous close(U.S.) $50.25
  • High(U.S.) $50.93
  • Low(U.S.) $50.15
  • Bid / Ask-- / --
  • YTD % change-5.65%
  • Volume247,849
  • Average volume (10-day)364,394
  • Average volume (1-month)363,696
  • Average volume (3-month)335,105
  • 52-week range(U.S.) $38.30 to (U.S.) $62.50
  • Beta2.13
  • Trailing P/E19.22×
  • P/E 1 year forward17.63×
  • Forward PEG1.18×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.65
Updated March 22 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue1789911995
Total other revenue--------
Total revenue1789911995
Gross profit79384939
Total cost of revenue99627056
Total operating expense121808873
Selling / general / administrative18151414
Research & development3343
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1------
Other operating expenses, total--------
Operating income57193121
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax56193121
Income after tax38142115
Income tax, total185107
Net income3792015
Total adjustments to net income--------
Net income before extra. items38142115
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items38142115
Inc. avail. to common incl. extra. items3792015
Diluted net income3792015
Dilution adjustment0------
Diluted weighted average shares33333333
Diluted EPS excluding extraordinary itemsvalue per share1.150.420.630.45
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.170.420.630.45